About us

Mission

To safeguard human health, food systems, and economies through rapid, scalable, and accurate pathogen detection.

Our Business

Global Biosecurity Starts with Scalable Diagnostics

Avicena is an ISO 13485-certified Australian medical technology company developing advanced molecular diagnostic and biosecurity systems to protect communities and economies from disease outbreaks.Our Sentinel platform is the next generation in pathogen detection – automated, accurate, scalable, and suitable for both human and animal applications. Built on LAMP technology, it delivers PCR-level sensitivity and adapts easily to a wide range of pathogens.aHeadquartered in Perth, Australia, Avicena is expanding into the UK, US, and Middle East, partnering with governments, health providers, and industry to deliver scalable diagnostics through flexible business models including sales, rentals, and long-term service contracts.

a. Dewhurst, R.E., Heinrich, T., Watt, P. et al. Validation of a rapid, saliva-based, and ultra-sensitive SARS-CoV-2 screening system for pandemic-scale infection surveillance. Sci Rep 12, 5936 (2022). https://doi.org/10.1038/s41598-022-08263-4.

Our Technology

Scalable Pathogen Detection Platform

At the heart of Avicena is the Sentinel platform, an ultra-scalable rapid molecular diagnostic system.

Built around our continuous-flow LAMP technology, Sentinel delivers PCR-level accuracy with unmatched speed – processing up to 100,000 samples per day with results in under 30 minutes.a

From hospitals to airports, to rural communities and forward military bases, our instruments operate in ways conventional labs cannot.

Our Team

Leading the Future of Diagnostics

Avicena brings together a cross-disciplinary, world-class team of scientists, engineers, and commercial leaders.

Our executive team brings global experience in medical diagnostics, biotechnology, and advanced engineering – spanning product development, regulatory strategy, large-scale manufacturing, and commercial rollout.

Credentials

Listed IVD: Avicena Sentinel holds a Class 1 IVD listing on the Australian Register of Therapeutic Goods (ARTG) under the TGA.

ISO 13485 certified for the design, development, and manufacture of in vitro diagnostics.

CE-Marked for use in the in vitro diagnostic (IVD) molecular testing.

Patent-Pending

Avicena holds several patent pending innovations that enable our groundbreaking performance.

Latest News

Intended Use of the Avicena Sentinel instrument

The Avicena Sentinel instrument is intended for trained laboratory professionals to run human IVD isothermal amplification assays. Diagnostic use of the Sentinel requires IVD reagents and laboratory workflows which have been authorised by relevant regulatory agencies in each jurisdiction and by Avicena Systems as compatible with the instrument.

The Avicena Sentinel instruments are also available in configurations for research use, environmental/surveillance, animal health screening, and food safety testing.

AVICENA SENTINEL IS NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.

Avicena Sentinel is for in vitro diagnostic use in humans and animals.

Avicena Seguro is for animal health and research use only (RUO).

Contact an Avicena Systems representative for regional availablity.